Treatment of primary and metastatic carcinoma
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 12, 2016
Grant Date -
Dec 19, 2013
app pub date -
May 9, 2013
filing date -
May 9, 2012
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed are methods of treating a chemotherapy-resistant cancer, of treating a cholangiocarcinoma, of treating a metastatic carcinoma, and of treating a transition cell urothelial carcinoma by administering a therapeutically effective amount of an endothelin B (ETB) receptor agonist and a chemotherapeutic agent to a subject afflicted with such a cancer.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully